HTAC Recommendation on AstraZeneca COVID-19 vaccine as Second Booster/ Fourth Dose for the prevention of COVID-19 Date of OIC-SOH Approval: 14 November 2022 This assessment followed the HTAC evaluation framework to evaluate COVID-19 vaccines using the following criteria: (1) responsiveness to magnitude and severity; (2) clinical efficacy and safety; (3) affordability, viability and feasibility; (4) household continue reading : Evidence Summary on AstraZeneca COVID-19 vaccine as Second Booster/ Fourth Dose for the prevention of COVID-19
DOST Visit to the HTA Philippines Office
The transition team from the Department of Science and Technology (DOST) went to the Health Technology Assessment (HTA) Philippines office under the Department of Health (DOH) on 13 January 2023 to discuss status updates and align on the next steps, in parallel with the ocular inspection of facilities to prepare for the anticipated physical reporting continue reading : DOST Visit to the HTA Philippines Office
Evidence brief for 17 to 23 December 2022
For the period of 17 to 23 December 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: https://bit.ly/17 December- 23 December 2022 Document Preview:
HTAD and HTAC Stocktaking and Operational Planning for 2023 Workshop
In preparation for the 2023 implementation of Health Technology Assessment (HTA), a workshop was held on December 7-9, 2022 in Pampanga to discuss the 2022 best practices, gaps, challenges, and lessons learned, as well as the 2023 operational plans of the HTA Division and HTA Council. Prior to the workshop proper, the HTA Division had continue reading : HTAD and HTAC Stocktaking and Operational Planning for 2023 Workshop